Hung CF - Search Results

1

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

Chow PKH, Gandhi M, Tan SB, Khin MW, Khasbazar A, Ong J, Choo SP, Cheow PC, Chotipanich C, Lim K, Lesmana LA, Manuaba TW, Yoong BK, Raj A, Law CS, Cua IHY, Lobo RR, Teh CSC, Kim YH, Jong YW, Han HS, Bae SH, Yoon HK, Lee RC, Hung CF, Peng CY, Liang PC, Bartlett A, Kok KYY, Thng CH, Low AS, Goh ASW, Tay KH, Lo RHG, Goh BKP, Ng DCE, Lekurwale G, Liew WM, Gebski V, Mak KSW, Soo KC; Asia-Pacific Hepatocellular Carcinoma Trials Group. Chow PKH, et al. Among authors: hung cf. J Clin Oncol. 2018 Jul 1;36(19):1913-1921. doi: 10.1200/JCO.2017.76.0892. Epub 2018 Mar 2. J Clin Oncol. 2018. PMID: 29498924 Clinical Trial.

2

Sclerosing hepatocellular carcinoma: clinicopathologic features in seven patients from Taiwan and review of the literature.

Yeh CN, Hung CF, Lee KF, Chen MF. Yeh CN, et al. Among authors: hung cf. Hepatogastroenterology. 2005 Jul-Aug;52(64):1201-5. Hepatogastroenterology. 2005. PMID: 16001661 Review.

3

A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.

Yeh CT, Liang KH, Lin CC, Chang ML, Hsu CL, Hung CF. Yeh CT, et al. Among authors: hung cf. Int J Cancer. 2014 Mar 1;134(5):1214-24. doi: 10.1002/ijc.28439. Epub 2013 Sep 3. Int J Cancer. 2014. PMID: 23959947 Free article.

4

Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinoma.

Chan WH, Hung CF, Pan KT, Lui KW, Huang YT, Lin SY, Lin YY, Wu TH, Yu MC. Chan WH, et al. Among authors: hung cf. J Surg Oncol. 2016 Jun;113(7):789-95. doi: 10.1002/jso.24245. Epub 2016 Apr 7. J Surg Oncol. 2016. PMID: 27062288 Free PMC article.

5

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.

Surveillance group; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group. Surveillance group, et al. J Formos Med Assoc. 2018 May;117(5):381-403. doi: 10.1016/j.jfma.2017.09.007. Epub 2017 Oct 24. J Formos Med Assoc. 2018. PMID: 29074347 Free article.

6

A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib.

Chu YD, Lin KH, Huang YH, Lin CC, Hung CF, Yeh TS, Lee WC, Yeh CT. Chu YD, et al. Among authors: hung cf. Asia Pac J Clin Oncol. 2018 Oct;14(5):e341-e351. doi: 10.1111/ajco.12983. Epub 2018 May 21. Asia Pac J Clin Oncol. 2018. PMID: 29785761

7

Incorporation of biochemical factors for survival analysis of transarterial chemoembolization in patients with hepatocellular carcinoma: A retrospective cohort study.

Chan WH, Huang SF, Lee CW, Wu TH, Pan KT, Lin SM, Yu MC, Hung CF. Chan WH, et al. Among authors: hung cf. J Int Med Res. 2019 Oct;47(10):4862-4871. doi: 10.1177/0300060519866941. Epub 2019 Aug 26. J Int Med Res. 2019. PMID: 31446817 Free PMC article.

8

Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment.

Chang PY, Lee RC, Liang PC, Liu YS, Chuang VP, Wu DK, Cheng YF, Huang JI, Tseng HS, Hung CF, Wu RH, Chern MC, Cheng HM, Wu CH, Cheng SM, Chiang CL, Liang HL. Chang PY, et al. Among authors: hung cf. Front Oncol. 2023 Jun 20;13:1186674. doi: 10.3389/fonc.2023.1186674. eCollection 2023. Front Oncol. 2023. PMID: 37427137 Free PMC article. Review.

9

Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.

Lee RC, Liang PC, Liang HL, Chen YF, Yu CY, Cheng PN, Hung CF, Hsia CY, Lai HC, Ho MC, Cheng YF, Liu YS, Chao Y, Chen CH. Lee RC, et al. Among authors: hung cf. J Gastroenterol Hepatol. 2024 Apr 13. doi: 10.1111/jgh.16556. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38615197

10

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment.

Lin CC, Hung CF, Chen WT, Lin SM. Lin CC, et al. Among authors: hung cf. Liver Cancer. 2015 Dec;4(4):228-40. doi: 10.1159/000367737. Epub 2015 Oct 15. Liver Cancer. 2015. PMID: 26734578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

655 results

Search Page